Pharma Engineering ApS: Financial statements 2025
CVR: 42133590
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Pharma Engineering ApS (CVR 42133590) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 6,370 compared with DKK 1,475 the year before. Equity in the 2025 report amounted to DKK 51,317. The solvency ratio was 100%.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 6,370
- Equity
- DKK 51,317
- Total Assets
- DKK 51,317
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 0 | 6 t. | 51 t. | 0 |
| 2024 | - | 0 | 1 t. | 45 t. | 0 |
| 2023 | - | 0 | -4 t. | 43 t. | 0 |
| 2022 | - | 0 | 6 t. | 48 t. | 0 |
| 2021 | - | - | 2 t. | 42 t. | 0 |
How creditworthy is Pharma Engineering ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Pharma Engineering ApS has published its annual report for 2024. Gross profit came to DKK 0, and the net result was DKK 1,475.
About Pharma Engineering ApS
Pharma Engineering ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2021. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Mads Mose Onsberg. The company is owned by Mads Mose Onsberg. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 6,370 compared with DKK 1,475 the year before. Equity in the 2025 report amounted to DKK 51,317.